TABLE 4.
Independent Variable | Coefficient | 95% Confidence Interval |
---|---|---|
CD4 <201 (A) | 1.44* | 1.30, 1.59 |
CD4 201–350 (B) | 0.50* | 0.34, 0.67 |
CD4 351–500 (C) | 0.15 | –0.03, 0.32 |
CD4 >500 (reference) | — | — |
Years in care | ||
< 1 (reference) | — | — |
1–2 (1) | 0.59* | 0.40, 0.78 |
2–3 (2) | 1.03* | 0.79, 1.26 |
3–4 (3) | 1.16* | 0.90, 1.42 |
4–5 (4) | 1.32* | 1.01, 1.64 |
5–6 (5) | 1.60* | 1.26, 1.94 |
6–7 (6) | 1.85* | 1.46, 2.23 |
7–8 (7) | 2.19* | 1.77, 2.61 |
CD4 by years in care | ||
A-1 | –0.25† | –0.47, –0.03 |
A-2 | –0.40‡ | –0.68, –0.13 |
A-3 | –0.46‡ | –0.78, –0.15 |
A-4 | –0.36 | –0.73, 0.01 |
A-5 | –0.64* | –1.04, –0.25 |
A-6 | –0.70* | –1.14, –0.27 |
A-7 | –0.97* | –1.44, –0.49 |
B-1 | 0.07 | –0.18, 0.33 |
B-2 | 0.03 | –0.29, 0.34 |
B-3 | 0.07 | –0.29, 0.43 |
B-4 | 0.14 | –0.28, 0.56 |
B-5 | –0.06 | –0.50, 0.38 |
B-6 | –0.02 | –0.52, 0.49 |
B-7 | –0.23 | –0.80, 0.32 |
C-1 | 0.09 | –0.18, 0.36 |
C-2 | 0.01 | –0.33, 0.34 |
C-3 | 0.10 | –0.28, 0.47 |
C-4 | 0.36 | –0.09, 0.81 |
C-5 | 0.12 | –0.35, 0.59 |
C-6 | 0.17 | –0.37, 0.71 |
C-7 | –0.06 | –0.68, 0.55 |
Enrollment year | ||
2000 (reference) | ||
2001 | –0.05 | –0.16, 0.07 |
2002 | 0.01 | –0.10, 0.13 |
2003 | –0.12 | –0.24, 0.01 |
2004 | –0.14† | –0.26, –0.02 |
2005 | –0.40* | –0.53, –0.28 |
2006 | –0.37* | –0.50, –0.28 |
Male | –0.02 | –0.09, 0.06 |
Race/ethnicity | ||
White (reference) | — | — |
Black | 0.17* | 0.09, 0.26 |
Hispanic | 0.21* | 0.11, 0.30 |
Other | –0.11 | –0.29, 0.07 |
HIV risk group | ||
MSM (reference) | — | — |
HET | 0.07 | –0.01, 0.15 |
IDU | 0.17‡ | 0.08, 0.28 |
Other | 0.07 | –0.05, 0.18 |
Age group | ||
< 30 (reference) | — | — |
31–10 | 0.26* | 0.19, 0.34 |
41–50 | 0.31* | 0.22, 0.40 |
>50 | 0.41* | 0.28, 0.54 |
Model had gamma-distributed errors, resulting in variance proportional to the square of the mean, and a logarithmic link. Model also included indicators for each clinical site.
P < 0.001.
P < 0.05.
P < 0.01.
MSM indicates men who have sex with men; HET, heterosexual HIV transmission; IDU, injection drug use HIV transmission